A Qualitative Study of Women Prescription Drug Sellers

女性处方药销售商的定性研究

基本信息

批准号：
7467466
负责人：
Sheigla Brighid Murphy
金额：
$ 49.15万
依托单位：
SCIENTIFIC ANALYSIS CORPORATION
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-04-01 至 2011-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7467466
关键词：
18 year old Accident and Emergency department Accounting Address Admission activity Affect Agar Amphetamines Area Belief Benzodiazepines Central Nervous System Depressants Central Nervous System Stimulants Cocaine Crack Cocaine Criminal Justice Data Data Set Drug Prescriptions Drug abuse Drug usage Drug user Ethnography Exposure to Friends Funding Future Gender Health Heroin Illicit Drugs Intervention Interview Investigation Justice Law Enforcement Legal Literature Low income Marijuana Marketing Motivation NIH Program Announcements National Institute of Drug Abuse Nature Neighborhoods New York City Opioid Parents Participant Patients Pattern Pharmaceutical Preparations Pharmacologic Substance Powder dose form Prevention program Public Health Publishing Questionnaires Recruitment Activity Relative (related person)Reporting Research Research Personnel Research Project Grants Resources Risk Risk Factors Role Sales Sampling San Francisco Scientist Sex Characteristics Social Interaction Source System Techniques Testing Time United States Violence Woman Women&apos s Role Work base club drug comparison group design drug distribution drug market experience male men pill prescription drug abuse response social statistics therapy design

项目摘要

In response to the National Institute of Drug Abuse Program Announcement (PA- 07-329), specifically “gender differences in opportunity to use drugs, access to drugs, patterns of drugs use and factors affecting these differences,” we have designed a renewal for our ongoing research project entitled “A Qualitative Study of Women in Drug Markets” (R01DA018159), an investigation of women’s changing roles in drug markets. While conducting the interviews for the parent study, we discovered that women are not only selling marijuana, heroin, stimulants and club drugs (the four target groups for our current study) but they also sell prescribed and diverted pharmaceuticals. We propose to interview 50 women and a comparison group of 50 men who sell prescription drugs (opioids, stimulants and Central Nervous System [CNS] depressants), including drugs that have been prescribed for them, those they have purchased from other patients and pharmaceuticals diverted to illicit markets. The overall aim of this proposed 24-month project is to conduct a qualitative study of women prescription drug sellers in the San Francisco Bay Area. Employing ethnographic sampling techniques, we will recruit 100 participants who have sold or exchanged prescription drugs five or more times in the prior six months, who are 18 years of age or older and who reside in the San Francisco Bay Area. By extending the study to relatively low level sellers of prescription drugs, we hope to interview a full range of distributors, from users/sellers to sellers who do not use, from initiates to long term dealers, from sellers who sell one drug only to those who sell other drugs as well, from women who sell their own prescribed medications to wholesalers who sell diverted pharmaceuticals, and from those who sell to strangers to those who sell to friends or relatives. Project findings will fill the gap in the extant literature regarding the impact of gender on distribution practices and personal use patterns and, in turn, the health-related dangers for women who sell prescription drugs. This exploratory project will provide much needed information in order to design more effective and appropriate public health initiatives and interventions that are designed to target gender-sensitive, gender-specific and drug-specific risk factors.

In response to the National Institute of Drug Abuse Program Announcement (PA- 07-329), specifically “gender differences in opportunity to use drugs, access to drugs, patterns of drugs use and factors affecting these differences,” we have designed a renewal for our ongoing research project entitled “A Qualitative Study of Women in Drug Markets” (R01DA018159), an investment of women’s changing roles in drug markets.在进行父母研究的访谈时，我们发现女性不仅出售大麻，海洛因，兴奋剂和俱乐部药物（我们当前研究的四个目标群体），而且还出售了处方和转移的药品。我们建议采访50名妇女和一个由50名男性组成的比较组，他们出售处方药（阿片类药物，兴奋剂和中枢神经系统（CNS）抑制剂），包括为她们开处方的药物，这些药物是从其他患者购买的那些药物，而这些药物从其他患者那里购买的药物则转移到非法市场上。这个拟议的24个月项目的总体目的是对旧金山湾区的女性处方药销售商进行定性研究。使用民族志抽样技术，我们将招募100名在前六个月中出售或交换处方药的参与者，他们在18岁或以上且居住在旧金山湾区。 By extending the study to relatively low level sellers of prescription drugs, we hope to interview a full range of distributors, from users/sellers to sellers who do not use, from initiates to long term dealers, from sellers who sell one drug only to those who sell other drugs as well, from women who sell their own prescribed medications to wholesalers who sell diverted pharmaceuticals, and from those who sell to strangers to those who sell to friends or relatives.项目发现将填补有关性别对分销惯例和个人使用模式的影响的广泛文献中的空白，进而，对出售处方药的妇女造成的与健康相关的危险。该探索性项目将提供急需的信息，以设计更有效，适当的公共卫生计划和干预措施，这些计划旨在针对针对性别敏感，特定性别和药物的风险因素。